67 results on '"Beucher G"'
Search Results
2. Republication de : Infection intra-utérine : diagnostic et traitement. RPC rupture prématurée des membranes avant terme CNGOF
- Author
-
Beucher, G., Charlier, C., and Cazanave, C.
- Published
- 2019
- Full Text
- View/download PDF
3. Republication de : Rupture prématurée des membranes avant terme : recommandations pour la pratique clinique du CNGOF — Texte court
- Author
-
Schmitz, T., Sentilhes, L., Lorthe, E., Gallot, D., Madar, H., Doret-Dion, M., Beucher, G., Charlier, C., Cazanave, C., Delorme, P., Garabedian, C., Azria, É., Tessier, V., Senat, M.-V., and Kayem, G.
- Published
- 2019
- Full Text
- View/download PDF
4. Évaluation des pratiques professionnelles sur la prévention de l’allo-immunisation Rhésus D
- Author
-
Viaris de Lesegno, B., Beucher, G., Lamendour, N., D’Alché-Gautier, M.-J., Dreyfus, M., and Benoist, G.
- Published
- 2013
- Full Text
- View/download PDF
5. Avenir obstétrical après une première grossesse compliquée d’une prééclampsie sévère avec accouchement avant 34 SA
- Author
-
Lemonnier, M., Beucher, G., Morello, R., Herlicoviez, M., Dreyfus, M., and Benoist, G.
- Published
- 2013
- Full Text
- View/download PDF
6. Hémorragies du premier trimestre de la grossesse : orientations diagnostiques et prise en charge pratique
- Author
-
Benoist, G., Chéret-Benoist, A., Beucher, G., and Dreyfus, M.
- Published
- 2011
- Full Text
- View/download PDF
7. Anémie par carence martiale et grossesse. Prévention et traitement
- Author
-
Beucher, G., Grossetti, E., Simonet, T., Leporrier, M., and Dreyfus, M.
- Published
- 2011
- Full Text
- View/download PDF
8. Le diabète gestationnel: Référentiel élaboré par le Collège national des gynécologues et obstétriciens français (CNGOF) et par la Société francophone du diabète (SFD) – 2010
- Author
-
Vambergu, Anne, Lepercq, J., Vayssiere, C., Boulot, P., Burdet, I., Criballet, G., Fau, C., Grandjean, H., Simeoni, U., Vambergue, A., Beucher, G., Burguet, A., Cosson, E., Deruelle, P., Galtier, F., Guedj, A.-M., Guyard-Boileau, B., Hieronimus, S., Jacqueminet, S., Jannot-Lamotte, M.-F., Kerlan, V., Laloi-Michelin, M., Le meaux, J.-P., Mitanchez, D., Thiebaugeorges, O., Verier-Mine, O., and Virally, M.
- Published
- 2010
- Full Text
- View/download PDF
9. Complications maternelles des extractions instrumentales
- Author
-
Beucher, G.
- Published
- 2009
- Full Text
- View/download PDF
10. Prise en charge des fausses couches spontanées du premier trimestre
- Author
-
Beucher, G., Benoist, G., and Dreyfus, M.
- Published
- 2009
- Full Text
- View/download PDF
11. Prise en charge du dépassement de terme
- Author
-
Beucher, G. and Dreyfus, M.
- Published
- 2008
- Full Text
- View/download PDF
12. Prise en charge du HELLP syndrome
- Author
-
Beucher, G., Simonet, T., and Dreyfus, M.
- Published
- 2008
- Full Text
- View/download PDF
13. Sulfate de magnésium et pré-éclampsie sévère: Innocuité en pratique courante dans des indications ciblées
- Author
-
Girard, B., Beucher, G., Muris, C., Simonet, T., and Dreyfus, M.
- Published
- 2005
- Full Text
- View/download PDF
14. Complications obstétricales de l’obésité morbide
- Author
-
Grossetti, E., Beucher, G., Régeasse, A., Lamendour, N., Herlicoviez, M., and Dreyfus, M.
- Published
- 2004
- Full Text
- View/download PDF
15. Traitement médical des fausses couches spontanées précoces: Étude prospective d’une prise en charge ambulatoire à l’aide du misoprostol
- Author
-
Beucher, G., Baume, S., Bekkari, Y., Legrand-Horras, M., Herlicoviez, M., and Dreyfus, M.
- Published
- 2004
- Full Text
- View/download PDF
16. Démédicalisation du travail spontané chez les femmes à bas risque : impact sur le pronostic maternel et foetal.
- Author
-
Zeitoun, J., Beucher, G., Vardon, D., Louvez, L., and Dreyfus, M.
- Abstract
The objective of this study was to evaluate the obstetrical and neonatal consequences of a new protocol for the management of spontaneous labour in low-risk patients. This new algorithm was significantly associated with a longer period of complete dilatation in the nulliparous (P = 0.004), a decrease in the rate of amniotomy (P = 0.04), and a decrease in oxytocin consumption (P = 0.03). Increase in oxytocin use was also observed (P = 0.03). [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Pour l’utilisation du sulfate de magnésium dans la prévention de la crise d’éclampsie en cas de prééclampsie
- Author
-
Beucher, G. and Dreyfus, M.
- Published
- 2010
- Full Text
- View/download PDF
18. Mort fœtale in utero au-delà de 14 SA : induction du travail et obtention de la vacuité utérine.
- Author
-
Beucher, G., Dolley, P., Stewart, Z., Carles, G., Grossetti, E., and Dreyfus, M.
- Abstract
Résumé L’objectif de cette revue était d’évaluer les bénéfices et risques des méthodes d’induction du travail et d’évacuation utérine en cas de mort fœtale in utero au-delà de 14 semaines d’aménorrhée. Au deuxième trimestre, les données sont nombreuses mais de qualité méthodologique faible. En termes d’efficacité (délais induction-expulsion et taux d’expulsion dans les 24 heures) et de tolérance en l’absence d’antécédent de césarienne, le meilleur protocole d’induction du travail au deuxième trimestre de la grossesse semble être l’association mifépristone 200 mg par voie orale suivie 24–48 heures plus tard de l’administration vaginale de misoprotol 200 à 400 mg toutes les 4 à 6 heures. Au troisième trimestre, il existe très peu de données. Les circonstances sont semblables au déclenchement du travail sur fœtus viable. À terme ou à proximité du terme, l’oxytocine et la dinoprostone possèdent une AMM dans cette indication mais le misoprostol peut être une alternative selon le score de Bishop et aux posologies du déclenchement. En cas d’utérus cicatriciel, le risque de rupture utérine est augmenté lors d’une induction médicale du travail par les prostaglandines. Les doses minimales efficaces de misoprostol doivent être utilisées (100 à 200 μg toutes les 4 à 6 heures). La préparation cervicale préalable par l’administration de mifépristone et éventuellement par l’utilisation de laminaires semble essentielle dans cette situation. The objective of this review was to assess benefits and harms of different management options for induction of labor and obtaining of uterine vacuity in case of fetal death beyond of 14 weeks of gestation. In second-trimester, the data are numerous but low methodological quality. In terms of efficiency (induction-expulsion time and uterine evacuation within 24 hours rate) and tolerance in the absence of antecedent of caesarean section, the best protocol for induction of labor in the second-trimester of pregnancy appears to be mifepristone 200 mg orally followed 24–48 hours later by vaginal administration of misoprostol 200 to 400 μg every 4 to 6 hours. In third-trimester, there is very little data. The circumstances are similar to induction of labor with living fetus. A term or near term, oxytocin and dinoprostone have a marketing authorization in this indication but misoprostol may be an alternative as the Bishop score and dose of induction of labor with living fetus. In case of previous caesarean section, the risk of uterine rupture is increased in case of a medical induction of labor with prostaglandins. The lowest effective doses should be used (100 to 200 μg every 4 to 6 hours). Prior cervical preparation by the administration of mifepristone and possibly the use of laminar seems essential in this situation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
19. Fausses couches du premier trimestre : bénéfices et risques des alternatives thérapeutiques.
- Author
-
Beucher, G., Dolley, P., Stewart, Z., Carles, G., and Dreyfus, M.
- Subjects
- *
FIRST trimester of pregnancy , *MISCARRIAGE , *THERAPEUTICS , *MISOPROSTOL , *DISEASE complications ,RISK factors in miscarriages ,MEDICAL literature reviews - Abstract
Résumé L’objectif de cette revue était d’évaluer les bénéfices et les risques précoces et tardifs des traitements des fausses couches (FC) du premier trimestre de la grossesse. L’évacuation chirurgicale du produit de conception est le traitement le plus efficace et le plus rapide. Suivant la situation clinique, le traitement médical par le misoprostol (grossesse arrêtée) et la simple expectative (FC incomplète) peuvent être envisagés sans majorer les risques de complications hémorragiques et infectieuses. Ces alternatives obligent cependant à un suivi ambulatoire en général plus long avec des risques accrus de saignements prolongés et de chirurgie non programmée. The objective of this review was to assess early and late benefits and harms of different management options for first-trimester miscarriage. Surgical uterine evacuation remains the most effective and the quickest method of treatment. Depending on the clinical situation, medical treatment using misoprostol (missed miscarriage) or expectative attitude (incomplete miscarriage) does not increase the risk of complications, neither haemorrhagic nor infectious. However, these alternatives generally require longer outpatient follow-up, which leads to more prolonged bleeding and not planned surgical procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
20. Prise en charge obstétricale initiale en cas d’hémorragie du post-partum
- Author
-
Dreyfus, M., Beucher, G., Mignon, A., and Langer, B.
- Published
- 2004
- Full Text
- View/download PDF
21. Devenir à court terme des patientes ayant développé une prééclampsie sévère
- Author
-
Beucher, G., Simonet, T., and Dreyfus, M.
- Subjects
- *
PREECLAMPSIA , *PLACENTA , *DELIVERY (Obstetrics) , *HEMODYNAMICS , *PUERPERAL disorders , *DRUG administration , *TREATMENT effectiveness , *SYMPTOMS , *THERAPEUTICS - Abstract
Abstract: The delivery of the foetus and placenta remains the curative treatment for PE, usually allowing a spontaneous, quick and complete regression of all clinical signs and biological anomalies within the first days. However, the risk of developing complications associated with the condition persists mainly during the first 48 to 72hours and up to one week post partum. Post partum haemodynamic upset and the administered therapeutic measures are predisposing factors to these complications. This critical period therefore requires intensive monitoring and the delivery of appropriate treatments. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
22. Chapitre 25 - Dépassement de terme
- Author
-
Beucher, G.
- Full Text
- View/download PDF
23. Liste des collaborateurs
- Author
-
Almange, C., Andrès, P., Arcangeli-Belgy, M.-T., Artus, M., Assari, F., Bacq, Y., Bader, G., Balouet, P., Baraille, A., Bardin-Bedu, C., Beillat, T., Benoist, G., Beucher, G., Blanchère, J.-P., Blot, P., Boog, G., Boulogne, A.-I., Brasseur, G., Buzenet, C., Cabrol, D., Carbonne, B., Carbonneaux, S., Carles, G., Carluer, L., Chabrolle, J.-P., Coffin, C., Cournot, M.-P., Cuvelier, A., d'Ercole, C., Dallay, D., Dao, T., Dayan, J., de Guerke, L., Dejean, A., Delcroix, M., Deschamps, A., Desprats, R., Diguet, A., Dompmartin, A., Doyen, C., Dran, C., Dreyfus, M., Dupuis, O., Durier, M., Elefant, E., Evain-Brion, D., Faury, M.-N., Forgeard, C., Fournet, P., Fournier, T., Gabriel, R., Galley-Raulin, F., Galliot, L., Gaucherand, P., Giami, I., Goffinet, F., Golfier, F., Gomez, C., Gondry, J., Gouyon, J.-B., Grossetti, E., Grout, M.-A., Grynberg, M., Guillaume, S., Harvey, T., Hebert, A., Hillion, K., Himily, V., Houet-Zuccalli, T., Houssin, I., Kakol, M., Langer, B., Lansac, J., Lanta, S., Lavaud, M., Le Querrec, A., Lecointe-Jolly, V., Lejeune, V., Lemery, D., Lepercq, J., Leroy, S., Lestang, I., Longépé, J., Lo Presti, J.-P., Mahieu-Caputo, D., Maillet, R., Malassiné, A., Mandelbrot, L., Marpeau, L., Marpeau-Delignière, P., Marret, S., Martin, S., Massardier, J., Mercier, C., Moreau, Y., Morin, C., Muir, J.-F., Nguyen, F., Nivot-Roman, E., Nizard, J., Oury, J.-F., Pajot-Pharose, E., Parant, O., Paris, F., Polzin, K., Provost, D., Radi, S., Renner, J.-P., Reman, O., Revaux, A., Ricbourg, A., Riethmuller, D., Rivière, M., Roman, H., Rotten, D., Rozenberg, P., Schaal, J.-P., Schnitzler, K., Sentilhes, L., Sergent, F., Siegler, L., Simon, A., Simon-Toulza, C., Sutter-Dallay, A.-L., Szymansky, N., Teurnier, F., Trichot, C., Tsatsaris, V., Vallée, M.-M., Vauzelle, C., Venditelli, F., Vercoustre, L., Vérot, C., Verspyck, E., Viader, F., Winer, N., and Zanardi, M.
- Full Text
- View/download PDF
24. [Overview of induction of labor practices in France].
- Author
-
Blanc-Petitjean P, Salomé M, Dupont C, Crenn-Hebert C, Gaudineau A, Perrotte F, Raynal P, Clouqueur E, Beucher G, Carbonne B, Goffinet F, and Le Ray C
- Subjects
- Cohort Studies, Dinoprostone administration & dosage, Female, Fetal Membranes, Premature Rupture therapy, France, Gestational Age, Humans, Labor, Induced statistics & numerical data, Misoprostol administration & dosage, Oxytocin administration & dosage, Pregnancy, Pregnancy, Prolonged therapy, Prospective Studies, Labor, Induced methods, Practice Patterns, Physicians'
- Abstract
Objective: To describe induction of labor practices in France and to identify factors associated with the use of different methods., Methods: The data came from the French prospective population-based cohort MEDIP (MEthodes de Déclenchement et Issues Périnatales), including consecutively during one month in 2015 all women with induction of labor and a live fetus in 7 perinatal networks. The characteristics of women, maternity units, gestational age, Bishop's score, decision mode, indication and methods of labor induction were described. Factors associated with the use of different methods were sought in univariate analyzes., Results: The rate of induction of labor during the study was 21% and 3042 women were included (95.9% participation rate). The two main indications were prolonged pregnancy (28.7%) and premature rupture of the membranes (25.4%). More than one-third of women received intravenous oxytocin in first method, 57.3% prostaglandins, 4.5% balloon catheter and 1.4% another method. Among the prostaglandins, the vaginal device of dinoprostone was the most used (71.6%) then the gel (20.7%) and the vaginal misoprostol (6.7%). Women with a balloon were more often of higher body mass index and multiparous with scarred uterus. The balloon and misoprostol were mainly used in university public hospitals., Conclusions: The evolution of induction of labor methods, due to new data from the literature and the development of new drugs or devices, invites to regularly repeat population-based studies on induction of labor., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
25. [Preterm premature rupture of membranes: CNGOF Guidelines for clinical practice - Short version].
- Author
-
Schmitz T, Sentilhes L, Lorthe E, Gallot D, Madar H, Doret-Dion M, Beucher G, Charlier C, Cazanave C, Delorme P, Garabedian C, Azria É, Tessier V, Senat MV, and Kayem G
- Subjects
- Female, Fetal Death, Fetal Membranes, Premature Rupture epidemiology, France epidemiology, Gestational Age, Humans, Infant, Newborn, Infections, MEDLINE, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Premature Birth, Prognosis, Risk Factors, Fetal Membranes, Premature Rupture therapy
- Abstract
Objective: To determine management of women with preterm premature rupture of membranes (PPROM)., Methods: Bibliographic search from the Medline and Cochrane Library databases and review of international clinical practice guidelines., Results: In France, PPROM rate is 2 to 3% before 37 weeks of gestation (level of evidence [LE] 2) and less than 1% before 34 weeks of gestation (LE2). Prematurity and intra-uterine infection are the two major complications of PPROM (LE2). Compared to other causes of prematurity, PPROM is not associated with an increased risk of neonatal mortality and morbidity, except in case of intra-uterine infection, which is associated with an augmentation of early-onset neonatal sepsis (LE2) and of necrotizing enterocolitis (LE2). PPROM diagnosis is mainly clinical (professional consensus). In doubtful cases, detection of IGFBP-1 or PAMG-1 is recommended (professional consensus). Hospitalization of women with PPROM is recommended (professional consensus). There is no sufficient evidence to recommend or not recommend tocolysis (grade C). If a tocolysis should be prescribed, it should not last more than 48hours (grade C). Antenatal corticosteroids before 34 weeks of gestation (grade A) and magnesium sulfate before 32 weeks of gestation (grade A) are recommended. Antibiotic prophylaxis is recommended (grade A) because it is associated with a reduction of neonatal mortality and morbidity (LE1). Amoxicillin, 3rd generation cephalosporins, and erythromycin in monotherapy or the association erythromycin-amoxicillin can be used (professional consensus), for 7 days (grade C). However, in case of negative vaginal culture, early cessation of antibiotic prophylaxis might be acceptable (professional consensus). Co-amoxiclav, aminosides, glycopetides, first and second generation cephalosporins, clindamycin, and metronidazole are not recommended for antibiotic prophylaxis (professional consensus). Outpatient management of women with clinically stable PPROM after 48hours of hospitalization is a possible (professional consensus). During monitoring, it is recommended to identify the clinical and biological elements suggesting intra-uterine infection (professional consensus). However, it not possible to make recommendation regarding the frequency of this monitoring. In case of isolated elevated C-reactive protein, leukocytosis, or positive vaginal culture in an asymptomatic patient, it is not recommended to systematically prescribe antibiotics (professional consensus). In case of intra-uterine infection, it is recommended to immediately administer an antibiotic therapy associating beta-lactamine and aminoside (grade B), intravenously (grade B), and to deliver the baby (grade A). Cesarean delivery should be performed according to the usual obstetrical indications (professional consensus). Expectative management is recommended before 37 weeks of gestation in case of uncomplicated PPROM (grade A), even in case of positive vaginal culture for B Streptococcus, provided that an antibiotic prophylaxis has been prescribed (professional consensus). Oxytocin and prostaglandins are two possible options to induce labor in case of PPROM (professional consensus)., Conclusion: Expectative management is recommended before 37 weeks of gestation in case of uncomplicated PPROM (grade A)., (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
26. [Diagnosis and management of intra-uterine infection: CNGOF Preterm Premature Rupture of Membranes Guidelines].
- Author
-
Beucher G, Charlier C, and Cazanave C
- Subjects
- Aminoglycosides administration & dosage, Anti-Bacterial Agents therapeutic use, Escherichia coli Infections drug therapy, Female, Fever, France, Humans, Infections microbiology, Pregnancy, Pregnancy Complications, Infectious microbiology, Pregnancy Complications, Infectious therapy, Streptococcal Infections drug therapy, Streptococcus agalactiae, Uterine Diseases microbiology, beta-Lactams administration & dosage, Fetal Membranes, Premature Rupture microbiology, Infections diagnosis, Infections therapy, Pregnancy Complications, Infectious diagnosis, Uterine Diseases diagnosis, Uterine Diseases therapy
- Abstract
Objective: To determine the diagnosis criteria and management of intra-uterine inflammation or infection (Triple I, III)., Methods: PubMed and Cochrane Central databases search., Results: III is defined as an infection of the fetal membranes, and/or other components like the decidua, fetus, amniotic fluid or placenta. This word should be preferred to the word chorioamnionitis that is less precise (Professional consensus). III clinical signs exhibit poor limited sensibility and specificity (EL3). The diagnosis of III is retained in case of maternal fever (defined by a body temperature≥38°C) with no alternative cause identified and at least 2 signs among the following: fetal tachycardia>160 bpm for 10min or longer, uterine pain of labor, purulent fluid from the cervical canal (Professional consensus). Maternal hyperleukocytosis>20 giga/L in the absence of corticosteroids treatment or increased plasmatic C-reactive protein also argue for III, despite their limited sensibility and specificity (EL3). III requires prompt delivery (Grade A). III is not by itself an indication for cesarean delivery (Professional consensus). Antibiotic treatment should cover Streptococcus agalactiae and Escherichia coli. Antibiotics should be started immediately and maintained all over delivery, to reduce neonatal and maternal morbidity (Grade B). Treatment should rely on a combination of betalactamin and aminoglycoside (Grade B). After vaginal delivery, one single dose of antibiotic is required. Antibiotic duration should be longer in case of bacteremia. Longer duration could be considered in case of persistent fever or of cesarean delivery (Professional consensus)., (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
27. [Caesarean section at full dilatation: What are the risks to fear for the mother and child?]
- Author
-
Bruey N, Beucher G, Pestour D, Creveuil C, and Dreyfus M
- Subjects
- Adult, Birth Injuries epidemiology, Female, Humans, Hysterotomy methods, Infant, Newborn, Pregnancy, Retrospective Studies, Risk Factors, Cesarean Section adverse effects, Labor Stage, First
- Abstract
Objectives: Caesarean section is associated with increased maternal morbidity compared to a vaginal delivery, especially if it occurs during labour. Little data on caesarean section performed at full dilatation is available., Methods: This was a retrospective study done in University Hospital of type 3 over a period of ten years, including future primiparous patients who had a caesarean section performed at full dilatation, compared to a control group of patients whose caesarean section was conducted in first part of the labour. We collected different maternal data per- and postoperative and neonatal., Results: In total, 824 patients were enrolled including 412 in each group. For caesarean section at full dilatation, foetal extraction required more manoeuvres (RR=3.05; 95% CI: 2.1; 4.39; P<0.001); we noted more extension of hysterotomy (RR=1.79; 95% CI: 1.30; 2.46; P<0.001). Postoperative and neonatal maternal morbidity was not different, except more frequent neonatal trauma for caesarean section at full dilatation., Conclusion: A caesarean section at full dilatation has an excess intraoperative risk and requires great caution. Nevertheless, no significant increase of postoperative and neonatal complications can be proved., (Copyright © 2017 Elsevier Masson SAS. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. [Uterine artery pseudoaneurysm: an unusual cause of postpartum hemorrhage].
- Author
-
Delesalle C, Dolley P, Beucher G, Dreyfus M, and Benoist G
- Subjects
- Adult, Aneurysm, False diagnostic imaging, Aneurysm, False pathology, Female, Humans, Postpartum Hemorrhage diagnostic imaging, Postpartum Hemorrhage pathology, Pregnancy, Radiography, Ultrasonography, Uterine Artery diagnostic imaging, Aneurysm, False complications, Postpartum Hemorrhage etiology, Uterine Artery pathology
- Abstract
Uterine artery pseudoaneurysm is a rare complication of cesarean section. It can lead to severe postpartum hemorrhage. We report three cases of pseudoaneurysm diagnosed late after cesarean delivery, one followed by hemorrhagic shock. Ultrasound may point to the diagnosis, but arteriography of uterine arteries is decisive for the diagnosis. Selective artery embolization is recommended for treatment. Main advantages are complete occlusion of the pseudoaneurysm and fertility preservation., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
29. [Fetal death beyond 14 weeks of gestation: induction of labor and obtaining of uterine vacuity].
- Author
-
Beucher G, Dolley P, Stewart Z, Carles G, Grossetti E, and Dreyfus M
- Subjects
- Female, Humans, Misoprostol administration & dosage, Oxytocics administration & dosage, Pregnancy, Pregnancy Trimester, Second, Pregnancy Trimester, Third, Fetal Death, Labor, Induced
- Abstract
The objective of this review was to assess benefits and harms of different management options for induction of labor and obtaining of uterine vacuity in case of fetal death beyond of 14 weeks of gestation. In second-trimester, the data are numerous but low methodological quality. In terms of efficiency (induction-expulsion time and uterine evacuation within 24 hours rate) and tolerance in the absence of antecedent of caesarean section, the best protocol for induction of labor in the second-trimester of pregnancy appears to be mifepristone 200mg orally followed 24-48 hours later by vaginal administration of misoprostol 200 to 400 μg every 4 to 6 hours. In third-trimester, there is very little data. The circumstances are similar to induction of labor with living fetus. A term or near term, oxytocin and dinoprostone have a marketing authorization in this indication but misoprostol may be an alternative as the Bishop score and dose of induction of labor with living fetus. In case of previous caesarean section, the risk of uterine rupture is increased in case of a medical induction of labor with prostaglandins. The lowest effective doses should be used (100 to 200 μg every 4 to 6 hours). Prior cervical preparation by the administration of mifepristone and possibly the use of laminar seems essential in this situation., (Copyright © 2014. Published by Elsevier SAS.)
- Published
- 2015
- Full Text
- View/download PDF
30. [Definition of pregnancy losses: Standardization of terminology from the French National College of Obstetricians and Gynecologists (CNGOF)].
- Author
-
Delabaere A, Huchon C, Lavoue V, Lejeune V, Iraola E, Nedellec S, Gallot V, Capmas P, Beucher G, Subtil D, Carcopino X, Vialard F, Nizard J, Quibel T, Costedoat-Chalumeau N, Legendre G, Venditelli F, Rozenberg P, Lemery D, and Deffieux X
- Subjects
- Female, France, History, Medieval, Humans, Pregnancy, Abortion, Spontaneous, Fetal Death, Gynecology standards, Obstetrics standards, Pregnancy Outcome, Societies, Medical standards, Terminology as Topic
- Abstract
Objective: While a number of glossaries have been produced by various authorities in different countries, at present there is no internationally accepted common set of definitions for many terms used to describe pregnancy losses. The objective of the current study was to provide a standardized French/English terminology/glossary relating to pregnancy losses., Methods: Literature review, construction of a glossary and rating of proposals using a formal consensus method. The glossary was subject of a critical comprehensive review by a meeting of professionals (multidisciplinary panel)., Results: A miscarriage is a spontaneous evacuation of an intra-uterine pregnancy<22WG. A missed early miscarriage is when ultrasound (<14WG) shows no growth of intra-uterine sac/embryo and/or loss of fetal heart activity. An early miscarriage is when spontaneous evacuation of intra-uterine pregnancy occurs <14WG. A complete early miscarriage is when there is no retained products of conception (empty uterus on ultrasound) and no bleeding nor pain. Incomplete early miscarriage is when ultrasonography shows retained products of conception in the uterine cavity (including cervical canal). Repeat miscarriage or recurrent pregnancy loss is when the woman experiences 3 or more consecutive miscarriages <14WG. A late miscarriage is when there is spontaneous evacuation of pregnancy ≥14WG and <22WG. A threatened late miscarriage is when shortening/opening of the cervix±uterine contraction occur ≥14WG and <22WG. An intra-uterine fetal demise is when there is a spontaneous loss of fetal heart activity ≥14 WG., Conclusion: The final current terminology should be used by all healthcare professionals., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
31. [Pregnancy losses: Guidelines for clinical practice. Short text].
- Author
-
Huchon C, Deffieux X, Beucher G, Carcopino X, Costedoat-Chalumeau N, Delabaere A, Capmas P, Gallot V, Iraola E, Lavoue V, Legendre G, Lejeune-Saada V, Leveque J, Nedellec S, Nizard J, Quibel T, Subtil D, Vialard F, and Lemery D
- Subjects
- Abortion, Spontaneous prevention & control, Female, Fetal Death prevention & control, Humans, Pregnancy, Abortion, Spontaneous diagnosis, Abortion, Spontaneous therapy, Fetal Death etiology, Practice Guidelines as Topic standards
- Published
- 2014
- Full Text
- View/download PDF
32. [Methods used to provide guidelines for clinical practice concerning the management of pregnancy losses].
- Author
-
Deffieux X, Huchon C, Delabaere A, Lavoue V, Nedellec S, Gallot V, Capmas P, Beucher G, Carcopino X, Vialard F, Nizard J, Quibel T, Costedoat-Chalumeau N, Legendre G, and Lemery D
- Subjects
- Female, Humans, Pregnancy, Abortion, Spontaneous, Fetal Death, Practice Guidelines as Topic, Pregnancy Outcome
- Published
- 2014
- Full Text
- View/download PDF
33. [Epidemiology of loss pregnancy].
- Author
-
Delabaere A, Huchon C, Deffieux X, Beucher G, Gallot V, Nedellec S, Vialard F, Carcopino X, Quibel T, Subtil D, Barasinski C, Gallot D, Vendittelli F, Laurichesse-Delmas H, and Lémery D
- Subjects
- Female, Humans, Pregnancy, Abortion, Spontaneous epidemiology, Fetal Death, Pregnancy Outcome epidemiology
- Abstract
Objectives: Study of epidemiology of pregnancy loss., Materials and Method: A systematic review of the literature was performed using Pubmed and the Cochrane library databases and the guidelines from main international societies., Results: The occurrence of first trimester miscarriage is 12% of pregnancies and 25% of women. Miscarriage risk factors are ages of woman and man, body mass index greater than or equal to 25kg/m(2), excessive coffee drinking, smoking and alcohol consumption, exposure to magnetic fields and ionizing radiation, history of abortion, some fertility disorders and impaired ovarian reserve. Late miscarriage (LM) complicates less than 1% of pregnancies. Identified risk factors are maternal age, low level of education, living alone, history of previous miscarriage, of premature delivery and of previous termination of pregnancy, any uterine malformation, trachelectomy, existing bacterial vaginosis, amniocentesis, a shortened cervix and a dilated cervical os with prolapsed membranes. Fetal death in utero has a prevalence of 2% in the world and 5/1000 in France. Its main risk factors are detailed in the chapter., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
34. [Obtaining of uterine vacuity in pregnancy loss].
- Author
-
Beucher G, Dolley P, Stewart Z, Lavoué V, Deffieux X, and Dreyfus M
- Subjects
- Abortion, Spontaneous drug therapy, Abortion, Spontaneous surgery, Female, Humans, Pregnancy, Abortion, Spontaneous therapy, Fetal Death, Labor, Induced standards, Practice Guidelines as Topic standards, Pregnancy Trimester, First
- Abstract
Objective: To assess early and late benefits and harms of different management options for first trimester miscarriage and for induction of labor and obtaining of uterine vacuity in case of fetal death beyond of 14weeks of gestation., Methods: French and English publications were searched using PubMed and Cochrane Library., Results: Concerning missed miscarriage, expectant management is not recommended (LE1) because it increases the risk of failure, need of unplanned surgical procedure and blood transfusion (LE1). Surgical uterine evacuation remains more effective than medical treatment using misoprostol (LE1), but both techniques involve rare and comparable risks (EL1). When chosen, medical treatment should be a vaginal dose of 800μg of misoprostol, possibly repeated 24 to 48hours later (EL2). Administration of mifepristone prior to misoprostol is not recommended (EL2). In case of incomplete miscarriage, expectant management can be offered because it does not increase the risk of complications, neither haemorrhagic nor infectious (EL1). Medical treatment using misoprostol is not recommended (EL2) because it does not improve the evacuation rate when compared to our first option, and does not reduce the risk of complications (EL2). Surgical uterine evacuation leads to high evacuation rate (97-98%) and low risk of complications, haemorrhagic and infectious (<5%) (EL1). However, this option should not be the only one because of the good efficiency of the expectant management (more than 75% of evacuation) and comparably low risk of complications (EL1). Surgical aspiration should be favoured to curettage because it is quicker, less painful and leads to less bleeding (EL2). After a first trimester miscarriage future fertility is identical with each treatment (EL2). When a trophoblastic retention is suspected, a diagnostic hysteroscopy is recommended (EL2). In case of late intrauterine foetal death beyond 14weeks of gestation and without a past caesarean section, the most efficient protocol seems to be vaginal administration of misoprostol 200 to 400μg every 4 to 6hours (EL2). Twenty-four hours prior to misoprostol the administration of 200mg of mifepristone is recommended (EL3) because it improves the induction-expulsion time and diminishes the quantity of needed misoprostol (and so the complications linked to it) (EL3)., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
35. [Initial obstetrical management of post-partum hemorrhage following vaginal delivery].
- Author
-
Dolley P, Beucher G, and Dreyfus M
- Subjects
- Delivery, Obstetric standards, Female, Humans, Consensus, Delivery, Obstetric methods, Postpartum Hemorrhage prevention & control, Practice Guidelines as Topic standards
- Abstract
Objectives: To define initial steps of obstetrical treatment of post-partum hemorrhage (PPH) after vaginal delivery., Materials and Method: We searched the Medline and the Cochrane Library and checked the international guidelines: HAS, RCOG, SOGC, ACOG and WHO., Results: In case of PPH, the use of a collecting bag is recommended (professional consensus). All the concerned professional (midwife, obstetrician, anesthesiology team) must be warned immediately (professional consensus). If placenta is retained, manual removal needs to be performed and after placental delivery, manual uterine exploration is recommended (professional consensus). At the same time, a dose of 5 or 10 IU of oxytocin must be administrated IV over at least 1minute or directly by an intramuscular injection followed by an infusion of 5 to 10 UI/h during 2hours (professional consensus). In some situations at risk of cervical and high vaginal laceration, the low genital tract needs to be carefully examined (professional consensus). Appropriate management of PPH has to be known by the concerned professional (professional consensus). Retrospective study of each case of PPH should be done (professional consensus)., Conclusion: The PPH initial treatment involves a team work that, most of times, leads to stop the bleeding in least than 30minutes (professional consensus)., (Copyright © 2014. Published by Elsevier Masson SAS.)
- Published
- 2014
- Full Text
- View/download PDF
36. [Threatened late miscarriage. French guidelines].
- Author
-
Carcopino X, Barde K, Petrovic M, Beucher G, Capmas P, Huchon C, Deffieux X, d'Ercole C, and Bretelle F
- Subjects
- Female, France, Humans, Pregnancy, Abortion, Spontaneous diagnosis, Abortion, Spontaneous therapy, Practice Guidelines as Topic standards, Pregnancy Trimester, Second
- Abstract
Objectives: To define guidelines for the management of women diagnosed with threatened late miscarriage (TLM)., Materials and Methods: A systematic review of the literature was performed using Pubmed and the Cochrane library databases and the guidelines from main international societies., Results: Management of women diagnosed with threatened LM requires a complete history-taking searching for a previous history of LM and/or of premature delivery (Grade B). Speculum examination is required to diagnose membrane prolapse (Grade B) and vaginal ultrasound scan is recommended to measure the cervical length (Grade B). Finally, initial management should allow to rule out chorioamniotitis (Grade B). Vaginal progesterone therapy (90-200mg daily) is recommended for women diagnosed with a sole shortened cervix (<25mm) in mid-pregnancy (Grade A). Cerclage is only recommended in women with both history of previous premature delivery and/or previous LM and shortened cervical length diagnosed before 24 weeks of gestation (Grade A). Finally, cervical cerclage (Mc Donald technique) associated with systematic tocolytic therapy (indometacine) and antibiotics are to be recommended in women diagnosed with TLM with dilated cervical os eventually associated with membrane prolapse (GradeC)., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
37. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
- Author
-
Beucher G, Dolley P, Carles G, Salaun F, Asselin I, and Dreyfus M
- Subjects
- Abortifacient Agents, Nonsteroidal, Administration, Buccal, Administration, Intravaginal, Administration, Sublingual, Cervical Ripening, Female, France, Humans, Misoprostol adverse effects, Pregnancy, Pregnancy Trimester, First, Abortion, Induced methods, Misoprostol administration & dosage, Off-Label Use
- Abstract
Objective: State of knowledge about misoprostol's use out of its marketing authorization during the first trimester of pregnancy, in early miscarriage or to induce abortion or medical termination of pregnancy., Methods: French and English publications were searched using PubMed, Cochrane Library and international learned societies recommendations., Results: Cervical ripening prior to surgical uterine evacuation during the first trimester of pregnancy facilitates cervical dilatation and reduces operative time and uterine retention risk. Misoprostol, mifepristone and osmotic cervical dilators are equally efficient. Concerning first trimester miscarriage, surgical uterine evacuation remains the most effective and the quickest method of treatment (EL 1). Depending on the clinical situation, medical treatment using misoprostol (missed miscarriage) or expectative attitude (incomplete miscarriage) does not increase the risk of complications, neither haemorrhagic nor infectious (EL 1). However, these alternatives generally require longer outpatient follow-up, which leads to more consultations, prolonged bleeding and not planned surgical procedures (EL 1). Concerning missed miscarriage, a vaginal dose of 800 μg of misoprostol, possibly repeated 24 to 48 hours later, seems to offer the best efficiency/tolerance ratio (EL 2). Concerning early abortion, medical method is a safe and efficient alternative to surgery (EL 2). Success rates are inversely proportional to gestational age (EL 2). According to the modalities of its marketing authorization, 400 μg of misoprostol can only be given by oral route, for less than 7 weeks of amenorrhea (WA) pregnancies and after 36 to 48 hours following 600 mg of mifepristone (EL 1). However, 200mg of mifepristone is as efficient as 600 mg (EL 1). Beyond 7WA, misoprostol buccal dissolution (sublingual or prejugal) or vaginal administration are more efficient and better tolerated than oral ingestion (EL 1). Between 7 and 9WA, the best protocol in terms of efficiency and tolerance is the association of 200mg of mifepristone followed 24 to 48 hours later by 800 μg of vaginal, sublingual or buccal misoprostol (EL 1). An additional dose of 400 μg can be given 3 hours later if necessary (EL 3). In case of buccal administration, the dose of 400 μg seems to offer the same efficiency with a better tolerance but further evaluation is needed (EL 2). Between 9 and 12WA, medical treatment is less efficient than surgery and its tolerance is lower (EL 2). However, a protocol of 200mg of mifepristone followed 36 to 48 hours later by 800 μg of vaginal or sublingual misoprostol, plus an additional 400 μg dose every 3-4 hours (until 4-5 doses maximum) seems safe and efficient (EL 5)., Conclusion: Misoprostol use during the first trimester of pregnancy is a safe and efficient alternative to surgery as long as detailed protocols adjusted to each clinical situation are respected., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
38. [Status and expertise of off-label use of misoprostol in obstetrics and gynecology in France: study by CNGOF (short text)].
- Author
-
Marret H, Simon E, Beucher G, Dreyfus M, Gaudineau A, Vayssière C, Lesavre M, Pluchon M, Winer N, Fernandez H, Aubert J, Bejan-Angoulvant T, Jonville-Bera AP, Clouqueur E, Houfflin-Debarge V, Garrigue A, and Pierre F
- Subjects
- Abortifacient Agents, Nonsteroidal, Abortion, Induced methods, Female, France, Gestational Age, Humans, Labor, Induced, Oxytocics, Postpartum Hemorrhage prevention & control, Pregnancy, Gynecology methods, Misoprostol therapeutic use, Obstetrics methods, Off-Label Use
- Published
- 2014
- Full Text
- View/download PDF
39. [Failure of vacuum extractions: risk factors, maternal and fetal issues].
- Author
-
Le Brun C, Beucher G, Morello R, Jones F, Lamendour N, and Dreyfus M
- Subjects
- Apgar Score, Cesarean Section, Delivery, Obstetric methods, Dystocia, Female, Fetal Weight, Humans, Infant, Newborn, Labor Presentation, Pregnancy, Retrospective Studies, Risk Factors, Treatment Failure, Vacuum Extraction, Obstetrical adverse effects
- Abstract
Objectives: Determine cases which are at risk of vacuum extraction failure as well as maternal and foetal issues depending on the delivery outcome., Material and Methods: It was a retrospective study comparing 147 vacuum failures, from January 2002 to December 2010, with a control group randomly composed of 526 successful vacuum extractions. The outcomes were high risk situations of vacuum failure, maternal and neonatal morbidity depending on the delivery method (caesarean section or other instrumental extraction)., Results: The global vacuum failure rate was 3.3 %. During labour, we identified several situations at risk of vacuum extraction failure: cephalhematomas prior to extraction (P<0.001), deflexion attitude (P<0.001), posterior variety (P<0.001), entering above the inlet strait (P<0.001), occiput posterior delivery (P<0.001), fœtal weight greater than 3500g (P=0.023). Neonatals consequency were more Apgar score below 7 at five minutes life (P=0.007), fœtal acidosis (pH<7,20) (P=0.032), neonatal resuscitation (P<0.001), and craniofacial damages (P<0.001)., Conclusion: Many dystocic situations occurring during labour require intense care when practicing vacuum extraction since they more frequently result in failure. In case of vacuum extraction failure, immediate adaptation to extra-uterine life seems to be more difficult for new-born babies., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
40. [Continuous medical evaluation of the prevention of fetomaternal rhesus-D allo-immunization].
- Author
-
Viaris de Lesegno B, Beucher G, Lamendour N, D'Alché-Gautier MJ, Dreyfus M, and Benoist G
- Subjects
- Female, Guideline Adherence statistics & numerical data, Humans, Monitoring, Physiologic statistics & numerical data, Population Surveillance methods, Pregnancy, Professional Practice statistics & numerical data, Quality Control, Quality Improvement, Referral and Consultation statistics & numerical data, Rh Isoimmunization diagnosis, Clinical Audit, Practice Guidelines as Topic, Rh Isoimmunization prevention & control, Rho(D) Immune Globulin immunology
- Abstract
Objectives: To evaluate the prevention of fetomaternal rhesus-D allo-immunization between 2008 and 2010. This evaluation was a part of the continuous medical evaluation (CME) that is compulsory in French hospitals. It was carried out using the tools recommended by the Haute Autorité de santé. We followed the national guidelines for the prevention of fetomaternal rhesus-D allo-immunization as outlined in 2005 by the national French college of Obstetrics and Gynecology., Materials and Methods: We audited 3926 consultations in the first four months of 2008. Based on the results of the audit, actions were implemented to improve care. In 2009, we audited 4021 consultations to look for improvement, and another 3932 consultations in 2010., Results: In 2008, 14% of the patients had an overall optimal prevention. After actions were taken, 44% of patients in 2009 and 58% of patients in 2010 demonstrated optimal prevention (P<0,05). Especially, the prevention of fetomaternal allo-immunization has been explained for 43% of the patients in 2008 and to 90% of them in 2010. And immunoprophylaxia has been prescribed to 70% of the patients in 2008 and to 93% of them in 2010., Conclusion: This CME has resulted in a statistically significant improvement of the prevention of allo-immunization., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
41. [Subsequent pregnancy outcomes after first pregnancy with severe preeclampsia and delivery before 34 weeks of gestation].
- Author
-
Lemonnier M, Beucher G, Morello R, Herlicoviez M, Dreyfus M, and Benoist G
- Subjects
- Abruptio Placentae epidemiology, Birth Intervals, Female, Fetal Death epidemiology, Humans, Hypertension, Pregnancy-Induced epidemiology, Infant, Newborn, Infant, Small for Gestational Age, Parity, Pregnancy, Premature Birth epidemiology, Premature Birth etiology, Recurrence, Risk Factors, Gestational Age, Pre-Eclampsia physiopathology, Pregnancy Outcome, Premature Birth physiopathology
- Abstract
Objectives: Women who had severe preeclampsia are at high risk of gestational vascular complications (preeclampsia, gestational hypertension, fetal death, small for gestational age, placenta abruptio) in subsequent pregnancies. The aim of this study was to describe outcomes of subsequent pregnancy after severe preeclampsia with delivery before 34 weeks of gestation during the first pregnancy., Patients and Methods: One hundred and thirty-four primiparous women delivered before 34 weeks of gestation resulting in severe preeclampsia between January 2002 and December 2009. The data of the index pregnancy were identified from the medical record of our maternity, those of the subsequent pregnancy from paper or computerized medical records of the hospitals where deliveries took place. Our study ended on December 31 2011 for a decrease of at least 2 years after the index pregnancy., Results: Of the 75 subsequent pregnancies, 59 have been studied. Twenty patients (34%) had gestational vascular complications, in type of gestational hypertension alone (10%), preeclampsia (65%), isolated small for gestational age (20%) or fetal death (5%). Thirty-nine patients (66%) showed no recurrence of gestational vascular complications but only 33 patients (56%) had a pregnancy of course totally physiological. The only risk factor for recurrent gestational vascular complications in subsequent pregnancy was a long time interval between two pregnancies, with an increased risk in case of delay beyond 26 months., Conclusion: Women with a history of severe preeclampsia with delivery before 34 weeks of gestation during first pregnancy are at increased risk for gestational vascular complications during the next pregnancy. A close obstetrical monitoring is recommended during a subsequent pregnancy., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
42. [Maternal benefits and risks of trial of labor versus elective repeat caesarean delivery in women with a previous caesarean delivery].
- Author
-
Beucher G, Dolley P, Lévy-Thissier S, Florian A, and Dreyfus M
- Subjects
- Cesarean Section adverse effects, Cicatrix complications, Female, Humans, Maternal Mortality, Morbidity, Pregnancy, Risk Assessment, Risk Factors, Uterine Diseases complications, Uterine Rupture epidemiology, Cesarean Section, Repeat adverse effects, Pregnancy Outcome, Trial of Labor, Vaginal Birth after Cesarean adverse effects
- Abstract
Objective: To assess maternal outcomes during trial of labor (TOL) and elective repeat caesarean delivery (ERCD) in women with a previous caesarean delivery., Methods: French and English publications were searched using PubMed and Cochrane Library., Results: Maternal mortality remains a very rare event regardless of the planned mode of delivery (EL2). It is potentially reduced after a TOL but the presence of biases in many studies does not allow any conclusion (EL3). Maternal morbidity is mainly due to the failure of the TOL and to the risk of unplanned caesarean delivery during labor (EL2). The risk of complete uterine rupture significantly increases with TOL versus ERCD but it remains low at about 0.2 to 0.8% for women with one scar on the uterus (EL2). The occurrence of a post-surgical wound, mostly from the bladder, is rare (less than 0.5%) regardless of the planned mode of delivery (EL2). Facing the risk of hemorrhage requiring hysterectomy or blood transfusion, data are heterogeneous because of the nature of the populations studied. These risks do not seem to vary with the mode of delivery (EL3). The risk of post-partum venous thrombo-embolic complications and infections (endometritis and maternal fever) appears to be similar in both TOL and ERCD (EL3). The risk of infection is primarily related to the additional presence of obesity (EL2). While maternal morbidity progressively increases with the number of iterative caesarean sections, maternal morbidity in TOL after a previous caesarean delivery decreases with the number of successful TOL (EL2)., Conclusion: In patients with a previous caesarean delivery, the risks of maternal complications are rare and similar between TOL and ERCD. There is an increased risk of complete uterine rupture in case of TOL. Nevertheless TOL has a favorable benefit/risk balance in most cases and its success reduces the risk of short and long-term maternal complications (EL3)., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
43. [Acute pulmonary edema and pregnancy: a descriptive study of 15 cases and review of the literature].
- Author
-
Dolley P, Lebon A, Beucher G, Simonet T, Herlicoviez M, and Dreyfus M
- Subjects
- Acute Disease, Adult, Female, Gestational Age, Heart Diseases complications, Humans, Pre-Eclampsia physiopathology, Pregnancy, Pregnancy Complications physiopathology, Puerperal Disorders diagnosis, Puerperal Disorders etiology, Pulmonary Edema etiology, Tocolysis adverse effects, Pregnancy Complications diagnosis, Pulmonary Edema diagnosis
- Abstract
Objective: To describe the incidence and the etiologies of acute pulmonary edema (APE) and the diagnostic procedure used during pregnancy and immediate post-partum., Materials and Methods: We analyzed records from a search of codes of heart failure and APE as well as from the term "pulmonary edema" in computerized obstetric records from 2002 to 2010 in a university center of level 3. We identified maternal characteristics, the term of appearance and route of delivery, the time between symptoms and diagnosis, additional tests performed, and data from echocardiography., Results: Fifteen patients had an APE during pregnancy or in the immediate post-partum period during the study period (0.05%). The mean age was 28.6 years and the mean term of appearance was 31.2±3.1 weeks of amenorrhea. The diagnosis was made in 11 cases (73.3%) before delivery and in four during post-partum. The main etiology was preeclampsia (46.6%) followed by heart disease (26.7%), then tocolysis and overfilling (13.3%). In 55% of cases, we found a diagnostic wander characterized by carrying out further unnecessary tests. The echocardiography has led to a change in management in 27.3% of cases., Conclusion: The APE is a rare event during pregnancy and the post-partum period and its main etiology is preeclampsia. Some other etiologies are avoidable like the use of beta-agonists by intravenous route. The diagnosis is sometimes difficult, but the realization of a chest X-ray, a simple and inexpensive test, is enough to confirm it., (Copyright © 2012. Published by Elsevier Masson SAS.)
- Published
- 2012
- Full Text
- View/download PDF
44. [Iron deficiency anemia and pregnancy. Prevention and treatment].
- Author
-
Beucher G, Grossetti E, Simonet T, Leporrier M, and Dreyfus M
- Subjects
- Anemia, Iron-Deficiency complications, Blood Transfusion, Dietary Supplements adverse effects, Erythropoietin administration & dosage, Female, Humans, Injections, Intravenous adverse effects, Iron administration & dosage, Iron adverse effects, Pregnancy, Pregnancy Outcome, Recombinant Proteins, Anemia, Iron-Deficiency prevention & control, Anemia, Iron-Deficiency therapy, Pregnancy Complications, Hematologic prevention & control, Pregnancy Complications, Hematologic therapy
- Abstract
Objective: To assess the effectiveness and the safety of prevention and treatment of iron deficiency anemia during pregnancy., Methods: French and English publications were searched using PubMed and Cochrane library., Results: Early screening of iron deficiency by systematic examination and blood analysis seemed essential. Maternal and perinatal complications were correlated to the severity and to the mode of appearance of anemia. Systematic intakes of iron supplements seemed not to be recommended. In case of anemia during pregnancy, iron supplementation was not associated with a significant reduction in substantive maternal and neonatal outcomes. Oral iron supplementation increased blood parameters but exposed to digestive side effects. Women who received parenteral supplementation were more likely to have better hematological response but also severe potential side effects during pregnancy and in post-partum. The maternal tolerance of anemia motivated the choice between parenteral supplementation and blood transfusion., Conclusion: Large and methodologically strong trials are necessary to evaluate the effects of iron supplementation on maternal health and pregnancy outcomes., (Copyright © 2011 Elsevier Masson SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
45. [Maternal outcome of gestational diabetes mellitus].
- Author
-
Beucher G, Viaris de Lesegno B, and Dreyfus M
- Subjects
- Female, Humans, Pregnancy, Pregnancy Complications epidemiology, Pregnancy Complications etiology, Prognosis, Diabetes, Gestational diagnosis, Diabetes, Gestational therapy, Pregnancy Outcome
- Abstract
Objective: To estimate maternal outcome of treated or untreated gestational diabetes mellitus (GDM)., Methods: French and English publications were searched using PubMed and Cochrane library., Results: The diagnosis of GDM gathers a high risk population of preeclampsia and cesarean section (EL3). These risks are positively correlated with the level of hyperglycemia in a linear way (EL2). Intensive treatment of mild GDM compared with routine care reduces the risk of pregnancy-induced hypertension (preeclampsia, gestational hypertension). Moreover, it does not increase the risk of operative vaginal delivery, cesarean section and postpartum haemorrhage (EL1). Overweight, obesity and maternal hyperglycemia are independent risk factors for preeclampsia (EL2). Their association with GDM increases the risk of preeclampsia and cesarean section compared to diabetic women with normal body mass index (EL3). The association of several risk factors (such as advanced maternal age, pre-existing chronic hypertension, pre-existing nephropathy, obesity, suboptimal glycemic control) increases the risk of preeclampsia. In that case, the classical follow-up (blood pressure measurement, proteinuria) should be more frequent than monthly (professional consensus). The risk of cesarean section is increased by macrosomia, whether it was prenatally suspected or not. But this increased risk remains whatever the birth weight is (EL3). Diagnosis and treatment of GDM do not reduce the risk of severe perineal lesions, operative vaginal delivery and postpartum haemorrhage (EL2). Some psychological symptoms, such as anxiety and alteration of self-perception, can occur at the diagnosis of GDM (EL3). The treatment of GDM seems to reduce the risk of postpartum depression symptoms (EL2)., Conclusion: Most of the informations published on GDM cover the risks of preeclampsia and cesarean section. Intensive care of GDM reduces theses risks. The pregnancy follow-up should be adjusted to the risk factors., (Copyright © 2010 Elsevier Masson SAS. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
46. [Management of spontaneous miscarriage in the first trimester].
- Author
-
Beucher G
- Subjects
- Abortifacient Agents, Nonsteroidal therapeutic use, Abortion, Spontaneous diagnosis, Abortion, Spontaneous drug therapy, Education, Medical, Continuing, Endosonography, Female, Humans, Misoprostol therapeutic use, Pregnancy, Treatment Outcome, Abortion, Spontaneous diagnostic imaging, Abortion, Spontaneous surgery, Pregnancy Trimester, First
- Published
- 2010
- Full Text
- View/download PDF
47. [Early postpartum management of patients with severe preeclampsia].
- Author
-
Beucher G, Simonet T, and Dreyfus M
- Subjects
- Female, Humans, Practice Guidelines as Topic, Pregnancy, Prognosis, Puerperal Disorders epidemiology, Puerperal Disorders etiology, Puerperal Disorders therapy, Severity of Illness Index, Time Factors, Pre-Eclampsia
- Abstract
The delivery of the foetus and placenta remains the curative treatment for PE, usually allowing a spontaneous, quick and complete regression of all clinical signs and biological anomalies within the first days. However, the risk of developing complications associated with the condition persists mainly during the first 48 to 72 hours and up to one week post partum. Post partum haemodynamic upset and the administered therapeutic measures are predisposing factors to these complications. This critical period therefore requires intensive monitoring and the delivery of appropriate treatments., (Copyright 2010. Published by Elsevier SAS.)
- Published
- 2010
- Full Text
- View/download PDF
48. [Bleeding in the first trimester of pregnancy: diagnostic approach and therapeutic management].
- Author
-
Benoist G, Chéret-Benoist A, Beucher G, and Dreyfus M
- Subjects
- Diagnosis, Differential, Education, Medical, Continuing, Female, Humans, Pregnancy, Pregnancy Complications, Cardiovascular etiology, Risk Factors, Treatment Outcome, Uterine Hemorrhage etiology, Pregnancy Complications, Cardiovascular diagnosis, Pregnancy Complications, Cardiovascular therapy, Pregnancy Trimester, First, Uterine Hemorrhage diagnosis, Uterine Hemorrhage therapy
- Published
- 2010
- Full Text
- View/download PDF
49. [Efficiency of magnesium sulfate for the prevention of eclampsia in women with preeclampsia].
- Author
-
Beucher G and Dreyfus M
- Subjects
- Calcium Channel Blockers therapeutic use, Female, Humans, Infant, Newborn, Infant, Premature, Obstetric Labor, Premature prevention & control, Pre-Eclampsia prevention & control, Pregnancy, Treatment Outcome, Central Nervous System Diseases prevention & control, Eclampsia prevention & control, Infant, Premature, Diseases prevention & control, Magnesium Sulfate therapeutic use, Neuroprotective Agents therapeutic use
- Published
- 2010
- Full Text
- View/download PDF
50. [Management of the first trimester miscarriages].
- Author
-
Beucher G, Benoist G, and Dreyfus M
- Subjects
- Abortifacient Agents, Abortion, Spontaneous diagnostic imaging, Female, Humans, Misoprostol therapeutic use, Placenta, Retained diagnosis, Placenta, Retained drug therapy, Placenta, Retained surgery, Pregnancy, Pregnancy Trimester, First, Ultrasonography, Abortion, Spontaneous drug therapy, Abortion, Spontaneous surgery
- Abstract
A first trimester miscarriage is most often painfully experienced by the patients. The practitioner should be able to offer appropriate, timely, efficient and safe medical management, allowing a shorter convalescence without effect on subsequent fertility. Each step of the process of the miscarriage results in clinical and ultrasonographic characteristics, and requires a specific therapeutic strategy. Vaginal ultrasound allows confirmation of early pregnancy failure (missed miscarriage) diagnosis and to estimate the complete or incomplete removal of trophoblastic material. However, the endometrial thickness does not appear to be predictive for the risk of persistent bleeding or secondary surgery. Surgical evacuation of the product of conception remains the most effective and the quickest method of treatment. Depending on the clinical situation, medical treatment with misoprostol (missed miscarriage) or expectative attitude (incomplete miscarriage) do not increase the risk of complications, particularly the infectious one. However, these alternatives generally require more prolonged outpatient follow-up leading to more frequent consultations and surgical emergencies.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.